CTRI/2023/06/053430尚未招募Unknown
Immunoprofiling of BRAFV600E in precancerous and cancerous lesions of breast by immunohistochemistry and its association with clinicopathological features.
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •The cases diagnosed on biopsy or surgical specimen of breast cancer.
排除标准
- •1. Breast Biopsy with inflammatory histomorphology.
- •2. The biopsy without representative histomorphology of precancerous and cancerous lesion.
- •3. Deficient clinical data and details.
研究者
相似试验
尚未招募
Unknown
To study gene mutations in colorectal cancer enzymatically.CTRI/2023/05/053332Shreya Giri Goswami
已完成
不适用
Detection of BRAF Mutation on FNAB From Papillary Thyroid CarcinomaPapillary Thyroid CarcinomaNCT02561533University of Aarhus53
Unknown
不适用
Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase InhibitorsDifferentiated Thyroid CancerNCT01700699University of Salerno50
Unknown
1 期
Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal CancerBRAF V600E-mutated /MSS Metastatic Colorectal CancerVemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyNCT05019534West China Hospital12
招募中
2 期
eo- and adjuvant targeted therapy in BRAF-mutated anaplastic cancer of the thyroidBRAF V600-mutant anaplastic thyroid cancer10014713NL-OMON51864Academisch Medisch Centrum20